Viswanath Gunda
Stanford University(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Thyroid Cancer Diagnosis and Treatment, Cancer-related Molecular Pathways, Nanoplatforms for cancer theranostics
Most-Cited Works
- → CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation(2017)756 cited
- → Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids(2017)559 cited
- → Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism(2010)228 cited
- → Anti-androgenic endocrine disrupting activities of chlorpyrifos and piperophos(2010)111 cited
- → Anti‐PD‐1/PD‐L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer(2018)108 cited
- → Effects of flavonoid-rich extract from seeds of Eugenia jambolana (L.) on carbohydrate and lipid metabolism in diabetic mice(2008)104 cited
- → Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer(2016)101 cited
- → Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer(2018)100 cited
- → Nuclear Receptor SHP, a Death Receptor That Targets Mitochondria, Induces Apoptosis and Inhibits Tumor Growth(2010)94 cited
- → Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer(2016)87 cited